IFAA has been on the front lines of biosimilar entry to the marketplace, from participating in conventions and webinars about the topic to proudly serving on the Patients for Biologics Safety and Access (PBSA) Coalition alongside other major organizations in the United States.
Multidisciplinary Perspectives on the Emerging Biosimilars Landscape in Rheumatoid Arthritis
It's true. CEO, Tiffany Westrich-Robertson, taught college for eight years and even won "Favorite Teacher", voted on by the student body. Tami Caskey Brown taught fitness and Kelly Conway is currently in her 25th year as a speech and language pathologist and helped lead a project benefiting children with autism spectrum disorders or other developmental disabilities living in Uganda, Africa.
In addition to our founders, our IFAA Representatives (trained volunteers who help run IFAA projects) collectively have over two decades of teaching and training experience and some have recently earned a certificate "Foundations of Virtual Instruction" so they can better help implement our online programs.
Who better to teach the world - from other patients to supporters to researchers to the general public - about our diseases than educators who live with it every day?
Did you know that IFAA was founded by patients who are current and former educators?
Autoimmune/Autoinflammatory Arthritis vs Degenerative Arthritis (OA)
#LearnArthritis is the start of a global campaign to boost awareness to a level that can shift current world views and undo decades of misunderstandings surrounding the word arthritis. This should help patients gain more understanding and support from peers and the public, as well as lead to earlier detection, referrals, diagnosis and treatment. Learn More
This unique project uses a continued education (CE) video format - previously used to help doctors earn CME/CE credit - to answer the questions patients most want to understand about biosimilars and how this new medication will affect their treatment regimen as they enter the marketplace.
You can also submit additional questions to IFAA about biosimilars and what their emergence to market means for you. Learn more
IFAA will act as both nonprofit advisor and our CEO will contribute as the patient voice in conjunction with
It's like comparing apples and oranges
Copyright 2017. All rights reserved. Information on this site is intended for informational purposes only Our foundation does not engage in the practice of medicine. Please consult a physician to obtain personal healthcare and treatment options. Tax ID: 27-1214308